Guru Ownership Trend
Guru Analysis for Protara Therapeutics, Inc. (TARA)
Protara Therapeutics, Inc. (TARA), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $5.81 M.
Top institutional holders include Steven Cohen and Renaissance Technologies (RenTech).
Institutional sentiment is currently Bullish. This is evidenced by a $5.4 M net inflow during the quarter.
Recent activity highlights Steven Cohen who dramatically increased their stake. Conversely, Renaissance Technologies (RenTech) reduced exposure by 52.9%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Protara Therapeutics, Inc. (TARA)
Major holders include Steven Cohen ($6.01 M), Renaissance Technologies (RenTech) ($654,897), Cliff Asness ($348,053). According to the latest reported data, 3 tracked investment managers collectively hold approximately 1.35 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $5.4 M, with 2 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited TARA. The total reported sell value was $735,167.47.
Yes, 0 managers opened new positions in TARA, and 2 increased their existing holdings. The total reported buy value was $6.13 M.